Updates are available Correction dated 2023-03-13

Article History

Received: 31 August 2022

Accepted: 8 December 2022

First Online: 21 December 2022

Change Date: 13 March 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13063-023-07219-x

Declarations

:

: The study protocol was approved by the Swedish Ethical Review Board (registration number 410–14; amendments T124-15; 2020–02471; 2021–03320, 2021–05878-02). The participants receive information on what data is collected about them, that the data will be analyzed and coded, and that no unauthorized person will have access to the data. The information also includes that participants’ samples only are used in a way for which participants have given consent. The samples can only become relevant in new research projects if the participant gives new consent and/or approval from the Ethical Review Authority. Written, informed consent to participate will be obtained from all participants. Patients can withdraw their consent at any time during the study without any explanation. They can also request that their biological samples are destroyed or de-identified (untraceable to any person). The participants are offered compensation for extra travel related to the study. There is no anticipated harm or other compensation for trial participation.

: Not applicable.

: The authors declare that they have no competing interests.